AV 608
Alternative Names: AV-608; CGP-60829; NK-608; NKP 608C; NKP608Latest Information Update: 19 Jul 2010
At a glance
- Originator Novartis
- Developer Avera Pharmaceuticals
- Class Anxiolytics; Piperidines; Quinolines
- Mechanism of Action Neurokinin 1 antagonists; Substance P inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Irritable bowel syndrome; Overactive bladder; Social phobia
Most Recent Events
- 19 Jul 2010 Discontinued - Phase-I for Irritable bowel syndrome in USA (PO)
- 19 Jul 2010 Discontinued - Phase-II for Overactive bladder in Netherlands (PO)
- 19 Jul 2010 Discontinued - Phase-II for Overactive bladder in United Kingdom (PO)